Jang IJ - Search Results

1

Prediction of Drug-Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation.

Yoon DY, Lee S, Jang IJ, Kim M, Lee H, Kim S, Kim B, Song GS, Rhee SJ. Yoon DY, et al. Among authors: jang ij. Pharmaceutics. 2021 Sep 16;13(9):1489. doi: 10.3390/pharmaceutics13091489. Pharmaceutics. 2021. PMID: 34575565 Free PMC article.

2

Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: an open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers.

Lee S, Chung YJ, Kim BH, Shim JH, Yoon SH, Shin SG, Jang IJ, Yu KS. Lee S, et al. Among authors: jang ij. Clin Ther. 2009 Dec;31(12):3000-8. doi: 10.1016/j.clinthera.2009.12.004. Clin Ther. 2009. PMID: 20110037 Clinical Trial.

3

Relative bioavailability and tolerability of two formulations of bicalutamide 50-mg tablets: a randomized-sequence, open-label, two-period crossover study in healthy Korean male subjects.

Lee S, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS. Lee S, et al. Among authors: jang ij. Clin Ther. 2010 Dec;32(14):2496-501. doi: 10.1016/j.clinthera.2011.01.017. Clin Ther. 2010. PMID: 21353117 Clinical Trial.

4

Effect of CYP2C19 polymorphism on the pharmacokinetics of voriconazole after single and multiple doses in healthy volunteers.

Lee S, Kim BH, Nam WS, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS. Lee S, et al. Among authors: jang ij. J Clin Pharmacol. 2012 Feb;52(2):195-203. doi: 10.1177/0091270010395510. J Clin Pharmacol. 2012. PMID: 21383338 Clinical Trial.

5

Voriconazole-associated severe hyponatremia.

Kim KH, Lee S, Lee S, Yun NR, Kim NJ, Yu KS, Jang IJ, Park WB, Oh MD. Kim KH, et al. Among authors: jang ij. Med Mycol. 2012 Jan;50(1):103-5. doi: 10.3109/13693786.2011.587210. Epub 2011 Jun 15. Med Mycol. 2012. PMID: 21671829

6

Immunogenicity and safety of a single intramuscular dose of a diphtheria-tetanus toxoid (Td) vaccine (GC1107) in Korean adults.

Lee S, Park WB, Shin KH, Ahn DH, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS. Lee S, et al. Among authors: jang ij. Vaccine. 2011 Oct 13;29(44):7638-43. doi: 10.1016/j.vaccine.2011.08.003. Epub 2011 Aug 22. Vaccine. 2011. PMID: 21864613 Clinical Trial.

7

Pharmacokinetic and pharmacodynamic properties of the calcimimetic agent cinacalcet (KRN1493) in healthy male Korean subjects: a randomized, open-label, single ascending-dose, parallel-group study.

Lee S, Gu N, Kim BH, Lim KS, Shin SG, Jang IJ, Yu KS. Lee S, et al. Among authors: jang ij. Clin Ther. 2012 May;34(5):1160-9. doi: 10.1016/j.clinthera.2012.03.058. Epub 2012 Apr 13. Clin Ther. 2012. PMID: 22503212 Clinical Trial.

8

Apple juice greatly reduces systemic exposure to atenolol.

Jeon H, Jang IJ, Lee S, Ohashi K, Kotegawa T, Ieiri I, Cho JY, Yoon SH, Shin SG, Yu KS, Lim KS. Jeon H, et al. Among authors: jang ij. Br J Clin Pharmacol. 2013 Jan;75(1):172-9. doi: 10.1111/j.1365-2125.2012.04324.x. Br J Clin Pharmacol. 2013. PMID: 22574741 Free PMC article. Clinical Trial.

9

Multiple-dose pharmacokinetics of fesoterodine sustained-release in healthy Korean volunteers.

Shin D, Shin KH, Lee S, Lim KS, Cho JY, Jang IJ, Shin SG, Yu KS. Shin D, et al. Among authors: jang ij. Int J Clin Pharmacol Ther. 2012 Oct;50(10):722-8. doi: 10.5414/CP201708. Int J Clin Pharmacol Ther. 2012. PMID: 22853865 Clinical Trial.

10

Pharmacokinetic study of single and multiple oral administrations of 2 mg dienogest in healthy Korean women.

Shin D, Lee S, Lim KS, Park JS, Shin SG, Jang IJ, Yu KS. Shin D, et al. Among authors: jang ij. Contraception. 2013 Jun;87(6):750-5. doi: 10.1016/j.contraception.2012.10.033. Epub 2012 Dec 4. Contraception. 2013. PMID: 23218856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page